Clinical trial
EpiCor Clinical Study on Rapid Immune Modulating Effects
NCT05819424 is registered in ClinicalTrials.gov with Cargill as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EpiCor Clinical Study on Rapid Immune Modulating Effects
- Lead sponsor
- Cargill
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 16, 2023
- Completion date
- November 17, 2023
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
immune surveillance